JP2014505679A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505679A5
JP2014505679A5 JP2013546228A JP2013546228A JP2014505679A5 JP 2014505679 A5 JP2014505679 A5 JP 2014505679A5 JP 2013546228 A JP2013546228 A JP 2013546228A JP 2013546228 A JP2013546228 A JP 2013546228A JP 2014505679 A5 JP2014505679 A5 JP 2014505679A5
Authority
JP
Japan
Prior art keywords
animal
dgla
composition
probiotics
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013546228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/065173 external-priority patent/WO2012087745A1/en
Publication of JP2014505679A publication Critical patent/JP2014505679A/ja
Publication of JP2014505679A5 publication Critical patent/JP2014505679A5/ja
Pending legal-status Critical Current

Links

JP2013546228A 2010-12-21 2011-12-15 変形性関節症の予防及び治療のための方法及び組成物 Pending JP2014505679A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
US61/459,902 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (2)

Publication Number Publication Date
JP2014505679A JP2014505679A (ja) 2014-03-06
JP2014505679A5 true JP2014505679A5 (enExample) 2015-01-29

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546228A Pending JP2014505679A (ja) 2010-12-21 2011-12-15 変形性関節症の予防及び治療のための方法及び組成物

Country Status (11)

Country Link
US (1) US20140205569A1 (enExample)
EP (1) EP2654744A4 (enExample)
JP (1) JP2014505679A (enExample)
CN (1) CN103384521A (enExample)
AU (1) AU2011349718B2 (enExample)
BR (1) BR112013018453A2 (enExample)
CA (1) CA2822263A1 (enExample)
MX (1) MX2013007191A (enExample)
RU (1) RU2013133998A (enExample)
WO (1) WO2012087745A1 (enExample)
ZA (1) ZA201305497B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
EP3151825B1 (en) 2014-06-04 2020-03-25 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
KR100490189B1 (ko) * 1995-08-07 2005-05-17 산토리 가부시키가이샤 오메가 9계 불포화 지방산을 포함하는, 연골 조직의 이상에 기인하는 의학적 증상의 예방 또는 치료제
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
ES2262667T3 (es) * 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
CN101653436B (zh) * 2003-08-11 2017-06-09 希尔氏宠物营养品公司 用于治疗犬骨关节炎的ω‑3脂肪酸
CN1901920B (zh) * 2003-11-21 2013-12-25 雀巢技术公司 含有氨基葡糖的食物组合物
CA2571742C (en) * 2004-07-01 2013-01-15 Nestec S.A. Canine osteoarthritis diet formulation
CA2599112C (en) * 2005-02-14 2013-10-22 Suntory Limited Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
CN101460185A (zh) * 2006-04-03 2009-06-17 雀巢产品技术援助有限公司 用于促进骨生长和维持骨健康的营养组合物及与其有关的方法

Similar Documents

Publication Publication Date Title
Bottegoni et al. Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis
IN2012DN00760A (enExample)
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
RU2012114786A (ru) Питательные композиции, содержащие экзогенный витамин к2
MX2009009318A (es) Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
JP2014505679A5 (enExample)
JP2015523321A5 (enExample)
MX347770B (es) Compuesto para el tratamiento de alteraciones neuropsiquiatricas.
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
WO2013166177A3 (en) Pterostilbene and curcumin combination for treatment of oxidative stress and inflammation
EA201000854A1 (ru) Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании
WO2011002298A3 (en) Animal feed or human food for improving intestinal barrier properties
EA201100154A1 (ru) Способ лечения заболеваний толстой кишки
RU2013133998A (ru) Способы и композиции для предотвращения и лечения остеоартрита
RU2017122615A (ru) Применение пробиотиков для усиления мужской фертильности
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS
WO2021074649A3 (en) Methods of promoting scfa production by gut microbiota
JP2017061488A5 (enExample)
RU2008126860A (ru) Способ повышения продуктивности и качества продукции овцеводства
RU2013154564A (ru) Способы и композиции для стимуляции роста безжировой массы тела
CN106413743A (zh) 用于关节炎、可动性和延缓衰老的组合物
MX2013006353A (es) Metodos y composiciones utiles para promover el sueño en animales.
WO2016008642A3 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
NZ613264A (en) Use of vitamin k for weight maintenance and weight control
WO2016027225A8 (en) A composition having a muscle-relaxant and anti-inflammatory activity